Fact CheckerSign in

NCT04596072Completed

A Clinical Trail of Integrative Medicine Approaches for Post-Stroke Cognitive Impairment

Source: ClinicalTrials.gov · Last updated 29 Apr 2025

Brief summary (registry, in English)

The traditional Chinese medicine rehabilitation for the post-stroke cognitive impairment will be intervened, which can promote the recovery of post-stroke cognitive function patients, reduce the disability rate and improve the quality of life.

Status (registry)
Completed
Study type
Interventional
Enrollment
122 (actual)
First submitted
10 Oct 2020
Start date
25 Apr 2019
Primary completion date
31 Dec 2024
Lead sponsor
The Third Affiliated hospital of Zhejiang Chinese Medical University
Diseases
Stroke
NCT number
NCT04596072

What you commit to

  • Study type: Interventional
  • Participants enrolled: 122
  • From 25 Apr 2019 to the primary completion date, 31 Dec 2024
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Cognitive impairment caused by subarachnoid hemorrhage, transient ischemic attack, or other intracranial lesions., such as tumors, aneurysms, vascular malformations, cysticercosis, schistosomiasis, encephalitis, meningitis, hydrocephalus, or head trauma;
  • non-atherosclerotic thrombotic cerebral infarction (such as cardiac embolism, procoagulant state, endovascular shedding, or arteritis);
  • severe chronic diseases of the heart, liver, kidneys, other viscera, or endocrine system or hematopoietic system;
  • severe dementia, serious language understanding disorders, or mental illness;
  • bleeding tendency;

Other

  • pregnant or lactating women;
  • lack of inclusion criteria or not suitable for clinical observation.

Who the study is looking for

  • Stroke as per the TCM definition, presenting symptoms include unilateral paresis or paralysis, sensory deficits, speech impairment, and hemianopsia. PSCI diagnosis involves clinically significant deficits in at least one cognitive domain and severe disruption of instrumental activity of daily livings.
  • age above 18 years;
  • disease duration of 30-180 days;
  • written informed consent by the patient's legal guardian;
  • MoCA (Montreal Cognitive Assessment) score of 17-26. If patient was educated for ≤ 12 years, one score will be deducted;
  • HAMD(Hamilton Depression Scale) score \< 20;
  • indications for acupuncture and moxibustion techniques.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
the Third Affiliated Hospital of Zhejiang Chinese Medical University
Coordinator of this site? Confirm its status
HangzhouChinaUnknown status
Hangzhou Hospital of Traditional Chinese Medicine
Coordinator of this site? Confirm its status
HangzhouChinaUnknown status
Jiaxing hospital of Chinese traditional medicine
Coordinator of this site? Confirm its status
JiaxingChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.